MANFREDINI, Rossella
 Distribuzione geografica
Continente #
NA - Nord America 17.818
AS - Asia 8.474
EU - Europa 8.087
SA - Sud America 1.198
AF - Africa 215
OC - Oceania 51
Continente sconosciuto - Info sul continente non disponibili 20
Totale 35.863
Nazione #
US - Stati Uniti d'America 17.520
GB - Regno Unito 2.553
SG - Singapore 2.411
CN - Cina 2.096
IT - Italia 1.706
HK - Hong Kong 1.339
VN - Vietnam 986
SE - Svezia 943
BR - Brasile 891
DE - Germania 617
FI - Finlandia 419
RU - Federazione Russa 416
FR - Francia 401
KR - Corea 348
UA - Ucraina 274
TR - Turchia 256
IN - India 199
CA - Canada 178
ID - Indonesia 157
BG - Bulgaria 120
BD - Bangladesh 111
NL - Olanda 107
AR - Argentina 99
MX - Messico 77
JP - Giappone 75
PL - Polonia 75
IQ - Iraq 74
SI - Slovenia 68
ZA - Sudafrica 65
PK - Pakistan 61
BE - Belgio 53
CO - Colombia 50
EC - Ecuador 48
AU - Australia 47
ES - Italia 47
IE - Irlanda 46
IR - Iran 42
LT - Lituania 40
KE - Kenya 37
CL - Cile 36
SA - Arabia Saudita 36
AE - Emirati Arabi Uniti 35
CZ - Repubblica Ceca 33
MA - Marocco 29
UZ - Uzbekistan 28
MY - Malesia 27
AT - Austria 24
PH - Filippine 24
TW - Taiwan 24
VE - Venezuela 21
DZ - Algeria 20
EG - Egitto 20
CH - Svizzera 19
TN - Tunisia 19
IL - Israele 18
NP - Nepal 16
PY - Paraguay 16
QA - Qatar 16
BO - Bolivia 15
PT - Portogallo 15
EU - Europa 13
AL - Albania 12
RO - Romania 12
PE - Perù 11
AZ - Azerbaigian 10
DK - Danimarca 10
GR - Grecia 10
JM - Giamaica 10
TH - Thailandia 10
RS - Serbia 9
HU - Ungheria 8
JO - Giordania 8
OM - Oman 8
UY - Uruguay 8
KG - Kirghizistan 7
LU - Lussemburgo 7
MN - Mongolia 7
BH - Bahrain 6
DO - Repubblica Dominicana 6
NI - Nicaragua 6
NO - Norvegia 6
PS - Palestinian Territory 6
AM - Armenia 5
BY - Bielorussia 5
CR - Costa Rica 5
EE - Estonia 5
KZ - Kazakistan 5
MD - Moldavia 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
TT - Trinidad e Tobago 5
GE - Georgia 4
HR - Croazia 4
KH - Cambogia 4
KW - Kuwait 4
NG - Nigeria 4
XK - ???statistics.table.value.countryCode.XK??? 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
GY - Guiana 3
Totale 35.811
Città #
Ashburn 1.876
Southend 1.849
Fairfield 1.588
Santa Clara 1.524
Singapore 1.465
Hong Kong 1.305
Chandler 1.015
Woodbridge 978
San Jose 787
Houston 740
Seattle 618
Ann Arbor 555
Wilmington 540
Cambridge 528
Nyköping 514
Hefei 501
Beijing 462
Jacksonville 436
Chicago 403
Dearborn 399
London 376
Los Angeles 355
Seoul 317
Modena 313
Ho Chi Minh City 299
Helsinki 286
Council Bluffs 248
Hanoi 220
New York 206
The Dalles 206
Salt Lake City 186
San Diego 166
Munich 128
Izmir 127
Milan 126
Princeton 123
Sofia 117
Jakarta 112
Shanghai 107
Buffalo 101
Lauterbourg 97
Bologna 94
São Paulo 90
Dallas 87
Moscow 87
Tampa 87
Eugene 86
Fremont 72
Elk Grove Village 67
Des Moines 64
Frankfurt am Main 64
Orem 64
Montreal 54
Tokyo 54
Bremen 53
Reggio Emilia 53
Rome 52
Turku 52
Da Nang 50
Warsaw 47
Brussels 46
Redwood City 44
Falls Church 43
Shenzhen 43
Dublin 42
Haiphong 41
Phoenix 41
Toronto 41
Miami 40
Sterling 38
Denver 37
Lancaster 37
Nuremberg 37
Falkenstein 36
Hillsboro 33
Boardman 31
Chennai 31
Columbus 31
Dong Ket 31
Johannesburg 31
Manchester 30
Ottawa 30
Atlanta 29
Parma 29
Brooklyn 28
Biên Hòa 27
Mexico City 27
Nairobi 27
Sant'Ilario d'Enza 25
Amsterdam 24
Florence 24
Rio de Janeiro 24
Baghdad 23
Detroit 23
Guangzhou 23
Tashkent 23
Brasília 22
Palermo 22
Paris 22
Poplar 22
Totale 24.834
Nome #
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms 556
c-Myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. 500
c-Myb supports erythropoiesis by transactivating KLF1 and LMO2 expression 465
Implementation of an NGS-based workflow for BRCA1 and BRCA2 mutation screening 455
miR-382-5p Controls Hematopoietic Stem Cell Differentiation Through the Downregulation of MXD1 431
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients 424
Virally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem/progenitor cells 420
C-Myb Restrains Megakaryopoiesis through the Hsa-MiR-486-3p-Driven Down-Regulation of C-Maf 417
Bone marrow-derived hematopoietic cells undergo myogenic differentiation following a Pax-7 independent pathway 415
Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells 410
Purinergic signaling inhibits human acute myeloblastic leukemia cell proliferation, migration, and engraftment in immunodeficient mice 402
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing 393
Correlation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursors 390
The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration 386
Co-culture of hematopoietic stem/progenitor cells with human osteblasts favours mono/macrophage differentiation at the expense of the erythroid lineage 379
Eosinophils, but not neutrophils, exibit an efficient DNA repair machinary and high nucleolar activity 378
Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1) 368
MicroRNA expression profile in granulocytes from primary myelofibrosis patients 365
miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6 364
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants 362
Amplicon-based Next Generation Sequencing: an effective approach to molecular diagnosis of Epidermolysis Bullosa 360
Mutations and prognosis in primary myelofibrosis 359
Transcriptional profiles in melanocytes from clinically unaffected skin distinguish the neoplastic growth pattern in patients with melanoma 358
Genomic landscape of megakaryopoiesis and platelet function defects 356
The kinetic status of hematopoietic stem cell subpopulations underlies a differential expression of genes involved in self-renewal, commitment, and engraftment. 355
Integrative Analysis Of mRNA/miRNA Expression Profiles Identified JARID2 As a Shared Target Of Deregulated Mirnas In Primary Myelofibrosis 353
Molecular profile of CD34+ stem/progenitor cells according to JAK2V617F mutation status in essential thrombocythemia. 351
Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa 347
Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells 346
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles 345
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis 344
Calreticulin affects hematopoietic stem/progenitor cell fate by impacting erythroid and megakaryocytic differentiation 343
Antisense inhibition of c-fes proto-oncogene blocks PMA-induced macrophage differentiation in HL60 and in FDC-P1/MAC-11 cells 342
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia 342
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group 338
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis 336
Requirement of the coiled-coil domains of p92(c-Fes) for nuclear localization in myeloid cells upon induction of differentiation 330
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 330
Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis 329
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study 324
Purinergic stimulation of human mesenchymal stem cells potentiates their chemotactic response to CXCL12 and increases the homing capacity and production of proinflammatory cytokines 323
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations 323
Preclinical study for treatment of hypospadias by advanced therapy medicinal products 319
Gene expression profile of vitamin D3 treated HL60 cells shows an incomplete molecular phenotypic conversion to monocytes 316
A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells 315
Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression 315
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 312
A functionally active RAR alpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines 311
Impact Of Prognostically Detrimental Mutations (ASXL1, EZH2, SRSF2, IDH1/2) On Outcomes In Patients With Myelofibrosis Treated With Ruxolitinib In COMFORT-II 298
Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages 289
Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patients 286
Expression And Function Of Nerve Growth-Factor And Nerve Growth-Factor Receptor On Cultured Keratinocytes. 283
Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features 282
Development of an IL-6 antagonist peptide that induces apoptosis in IL-6 dependent 7TD1 cells. 282
Antiapoptotic effect of c-fes protooncogene during granulocytic differentiation 279
Bone marrow-specific loss of ABI1 induces myeloproliferative neoplasm with features resembling, human myelofibrosis 277
AMPLICON-BASED NGS: AN EFFECTIVE APPROACH FOR THE MOLECULAR DIAGNOSIS OF EPIDERMOLYSIS BULLOSA 274
Wnt/CTNNB1 signal transduction pathway inhibits the expression of ZFP36 in squamous cell carcinoma, by inducing transcriptional repressors SNAI1, SLUG and TWIST 272
Role of CD34 antigen in myeloid differentiation of human hematopoietic progenitor cells 271
Terminal differentiation 268
The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells 266
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 265
Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib 263
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis 262
ANTISENSE STRATEGIES TO CHARACTERIZE THE ROLE OF GENES AND ONCOGENES INVOLVED IN MYELOID DIFFERENTIATION 261
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis 259
All-trans-retinoic acid induces simultaneously granulocytic differentiation and expression of inflammatory cytokines in HL-60 cells 257
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 254
Characterisation and discovery of novel miRNAs and moRNAs in JAK2V617F mutated SET2 cells 254
Molecular and functional characterization of CD133+ stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells 253
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms 252
Expression of B7 costimulatory molecule in cultured human epidermal Langerhans cells is regulated at the mRNA level. 251
BTK Inhibitors Impair Platelet-Mediated Antifungal Activity 251
Genomic analysis of hematopoietic stem cell at the single-cell level: Optimization of cell fixation and whole genome amplification (WGA) protocol 247
Presence of a functional vitamin D receptor does not correlate with vitamin D3 phenotypic effects in myeloid differentiation 244
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 241
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 236
Characterization of new ATM deletion associated with hereditary breast cancer 234
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis 233
Antisense strategies in leukemias 229
ROLE OF C-FES PROTOONCOGENE IN MYELOID DIFFERENTIATION 224
SOX2 Is a Univocal Marker for Human Oral Mucosa Epithelium Useful in Post-COMET Patient Characterization 224
Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms 222
Cytokine-induced killer cells express CD39, CD38, CD203a, CD73 ectoenzymes and P1 adenosinergic receptors 220
Automated capture-based NGS workflow: one thousand patients experience in a clinical routine framework 220
Gene Expression profile of Vitamin D3 treated HL60 cells shows a phenotypic but not a complete functional conversion to monocytes 216
Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells. the crucial role of PTEN. 215
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia 214
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: An international study of 797 patients 213
Novel Molecular Insights into Leukemic Evolution of Myeloproliferative Neoplasms: A Single Cell Perspective 210
Inhibition of c-fes expression by an antisense oligomer causes apoptosis oh HL60 cells induced to granulocytic differentiation 207
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 207
Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies 206
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: Pathogenetic insight and diagnostic value 206
Physiological levels of 1 alpha, 25 di-hydroxyvitamin D3 induce the monocytic commitment of CD34+ hematopoietic progenitors 205
Ivar, an interpretation‐oriented tool to manage the update and revision of variant annotation and classification 204
Neoantigen-specific T-cell immune responses: The paradigm of NPM1-mutated acute myeloid leukemia 204
Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in primary myelofibrosis 202
Increased Plasma Levels of lncRNAs LINC01268, GAS5 and MALAT1 Correlate with Negative Prognostic Factors in Myelofibrosis 199
ANTISENSE STRATEGIES IN LEUKEMIA 195
Totale 30.288
Categoria #
all - tutte 139.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.410


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021465 0 0 0 0 0 0 0 0 0 0 269 196
2021/20222.630 136 228 299 162 124 153 137 151 265 196 430 349
2022/20233.118 379 406 297 272 333 409 67 284 345 44 143 139
2023/20242.073 81 91 171 177 325 177 303 252 41 72 117 266
2024/20256.651 178 65 120 395 1.226 933 603 449 741 287 827 827
2025/202611.810 807 473 882 1.510 2.356 832 1.583 625 1.244 1.251 247 0
Totale 36.106